JP2015529192A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529192A5
JP2015529192A5 JP2015526970A JP2015526970A JP2015529192A5 JP 2015529192 A5 JP2015529192 A5 JP 2015529192A5 JP 2015526970 A JP2015526970 A JP 2015526970A JP 2015526970 A JP2015526970 A JP 2015526970A JP 2015529192 A5 JP2015529192 A5 JP 2015529192A5
Authority
JP
Japan
Prior art keywords
alkyl
dihydro
benzodiazepine
carboxamide
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015526970A
Other languages
English (en)
Japanese (ja)
Other versions
JP6333251B2 (ja
JP2015529192A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/066931 external-priority patent/WO2014026997A1/de
Publication of JP2015529192A publication Critical patent/JP2015529192A/ja
Publication of JP2015529192A5 publication Critical patent/JP2015529192A5/ja
Application granted granted Critical
Publication of JP6333251B2 publication Critical patent/JP6333251B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015526970A 2012-08-16 2013-08-13 2,3−ベンゾジアゼピン類 Expired - Fee Related JP6333251B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102012214602.4 2012-08-16
DE102012214602 2012-08-16
DE102013202104.6 2013-02-08
DE102013202104 2013-02-08
PCT/EP2013/066931 WO2014026997A1 (de) 2012-08-16 2013-08-13 2,3-benzodiazepine

Publications (3)

Publication Number Publication Date
JP2015529192A JP2015529192A (ja) 2015-10-05
JP2015529192A5 true JP2015529192A5 (enExample) 2018-02-08
JP6333251B2 JP6333251B2 (ja) 2018-05-30

Family

ID=48979774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015526970A Expired - Fee Related JP6333251B2 (ja) 2012-08-16 2013-08-13 2,3−ベンゾジアゼピン類

Country Status (22)

Country Link
US (1) US9890147B2 (enExample)
EP (1) EP2885286B1 (enExample)
JP (1) JP6333251B2 (enExample)
KR (1) KR20150041787A (enExample)
CN (1) CN104755473B (enExample)
AR (1) AR092129A1 (enExample)
AU (1) AU2013304146A1 (enExample)
CA (1) CA2881996A1 (enExample)
CL (1) CL2015000337A1 (enExample)
CR (1) CR20150066A (enExample)
DO (1) DOP2015000022A (enExample)
EA (1) EA201590356A1 (enExample)
EC (1) ECSP15005376A (enExample)
ES (1) ES2628005T3 (enExample)
IL (1) IL236898A0 (enExample)
MX (1) MX2015001880A (enExample)
PE (1) PE20150729A1 (enExample)
PH (1) PH12015500323A1 (enExample)
TN (1) TN2015000051A1 (enExample)
TW (1) TW201408651A (enExample)
UY (1) UY34977A (enExample)
WO (1) WO2014026997A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI568722B (zh) 2012-06-15 2017-02-01 葛蘭馬克製藥公司 作爲mPGES-1抑制劑之三唑酮化合物
CA2901352A1 (en) * 2013-02-19 2014-08-28 Bayer Pharma Aktiengesellschaft Bicyclo 2,3-benzodiazepines and spirocyclically substituted 2,3-benzodiazepines
EA035469B1 (ru) 2013-03-15 2020-06-22 Инсайт Холдингс Корпорейшн Трициклические гетероциклы как ингибиторы белков бэт
EP3019502B1 (en) 2013-07-08 2017-05-17 Incyte Holdings Corporation Tricyclic heterocycles as bet protein inhibitors
US9399640B2 (en) 2013-11-26 2016-07-26 Incyte Corporation Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
US9315501B2 (en) 2013-11-26 2016-04-19 Incyte Corporation Bicyclic heterocycles as BET protein inhibitors
US9309246B2 (en) 2013-12-19 2016-04-12 Incyte Corporation Tricyclic heterocycles as BET protein inhibitors
WO2015121226A1 (de) * 2014-02-13 2015-08-20 Bayer Pharma Aktiengesellschaft 6-substituierte 2,3-benzodiazepine
SMT202000133T1 (it) 2014-04-23 2020-05-08 Incyte Corp 1h-pirrolo[2,3-c]piridin-7(6h)-oni e pirazolo[3,4-c]piridin-7(6h)-oni come inibitori di proteine bet
JP6599979B2 (ja) 2014-09-15 2019-10-30 インサイト・コーポレイション Betタンパク質阻害剤として用いるための三環式複素環化合物
US10300073B2 (en) 2014-10-14 2019-05-28 The Regents Of The University Of California Use of CDK9 and BRD4 inhibitors to inhibit inflammation
WO2016062688A1 (de) * 2014-10-23 2016-04-28 Bayer Pharma Aktiengesellschaft 1-phenyl-4,5-dihydro-3h-2,3-benzodiazepine derivatives
GB201504694D0 (en) 2015-03-19 2015-05-06 Glaxosmithkline Ip Dev Ltd Covalent conjugates
WO2017005711A1 (de) * 2015-07-09 2017-01-12 Bayer Pharma Aktiengesellschaft Phosphor- und schwefel-substituierte benzodiazepin-derivate
WO2017063959A1 (de) * 2015-10-15 2017-04-20 Bayer Pharma Aktiengesellschaft N-sulfoximinophenyl-substituierte benzodiazepin-derivate als bet-proteininhibitoren
WO2017075377A1 (en) 2015-10-29 2017-05-04 Incyte Corporation Amorphous solid form of a bet protein inhibitor
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
DE102017005091A1 (de) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substituierte 3,4-Dihydropyrido[2,3-b]pyrazin-2(1H)-one
DE102017005089A1 (de) 2016-05-30 2017-11-30 Bayer Pharma Aktiengesellschaft Substitulerte 3,4-Dihydrochinoxalin-2(1H)-one
CN109715625B (zh) 2016-06-20 2022-04-19 因赛特公司 Bet抑制剂的结晶固体形式
WO2017191331A2 (en) * 2016-08-15 2017-11-09 Givaudan Sa Organic compounds
CN109406685B (zh) * 2018-12-27 2021-05-25 湖南泰新医药科技有限公司 一种分离卡非佐米和其异构体的高效液相色谱方法
US20220079952A1 (en) * 2019-05-24 2022-03-17 Emory University Uses of Radiation and Benzodiazepine Derivatives in Cancer Therapies
WO2021138391A1 (en) 2019-12-30 2021-07-08 Tyra Biosciences, Inc. Indazole compounds
WO2021152113A1 (en) 2020-01-31 2021-08-05 Bayer Aktiengesellschaft Substituted 2,3-benzodiazepines derivatives
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms
US12527741B2 (en) 2021-06-17 2026-01-20 Wisconsin Alumni Research Foundation Modular dendron micelles for treatment of pulmonary diseases related to fibrosis and viral infection including COVID-19
CN114920727B (zh) * 2022-05-26 2023-07-25 重庆华邦制药有限公司 一种卢帕他定的制备方法
WO2023229535A1 (en) 2022-05-27 2023-11-30 Engine Biosciences Pte. Ltd. Bet polypeptide therapeutic agents for generating synthetic lethality in tumors

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3483186A (en) * 1966-11-22 1969-12-09 Mcneilab Inc 2-benzazepine derivatives
HU208429B (en) 1991-05-03 1993-10-28 Gyogyszerkutato Intezet Process for producing 1-/3-chloro-phenyl/-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine of high purity
JP3239364B2 (ja) 1991-10-11 2001-12-17 ウェルファイド株式会社 骨粗鬆症治療薬およびジアゼピン化合物
WO1994006802A1 (fr) 1992-09-18 1994-03-31 Yoshitomi Pharmaceutical Industries, Ltd. Compose de thienodiazepine et son utilisation medicinale
WO1994026718A1 (fr) 1993-05-13 1994-11-24 Yoshitomi Pharmaceutical Industries, Ltd. Compose de 3-aminoazepine et son utilisation pharmaceutique
DE19604920A1 (de) 1996-02-01 1997-08-07 Schering Ag Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
US5891871A (en) 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
HU9600871D0 (en) * 1996-04-04 1996-05-28 Gyogyszerkutato Intezet New 2,3-benzodiazepine derivatives
PL330635A1 (en) 1996-06-12 1999-05-24 Japan Tobacco Inc Inhibitor of cytokin production, triazepin compound and intermediate compounds used for obtaining the last mentioned one
WO1998011111A1 (en) 1996-09-13 1998-03-19 Yoshitomi Pharmaceutical Industries, Ltd. Thienotriazolodiazepine compounds and medicinal uses thereof
EP1296960A2 (en) 2000-06-16 2003-04-02 Annovis, Inc. 5h-2,3-benzodiazepine antagonists of excitatory amino acid receptors
HU225100B1 (hu) * 2000-12-21 2006-06-28 Egyt Gyogyszervegyeszeti Gyar 2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
JP2005532291A (ja) 2002-04-12 2005-10-27 ファイザー株式会社 抗炎症薬および鎮痛薬としてのピラゾール化合物
US6858605B2 (en) * 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
GB0425196D0 (en) 2004-11-15 2004-12-15 Black James Foundation Gastrin and cholecystokinin receptor ligands
GB0503962D0 (en) 2005-02-25 2005-04-06 Kudos Pharm Ltd Compounds
WO2006129623A1 (ja) 2005-05-30 2006-12-07 Mitsubishi Tanabe Pharma Corporation チエノトリアゾロジアゼピン化合物及びその医薬としての用途
AU2006334172A1 (en) * 2005-12-30 2007-07-12 Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
DE102006042439A1 (de) 2006-09-09 2008-03-27 Saltigo Gmbh Verfahren zur katalytischen Herstellung von aromatischen oder heteroaromatischen Nitrilen
TW200902024A (en) * 2007-04-02 2009-01-16 Teva Pharma Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
JP2008308491A (ja) * 2007-05-11 2008-12-25 Gunma Univ がん治療用の遊走阻害剤
CN101910182B (zh) 2007-12-28 2013-07-17 田边三菱制药株式会社 抗癌剂
KR101435729B1 (ko) * 2009-09-28 2014-09-01 닛뽕소다 가부시키가이샤 함질소 헤테로 고리 화합물 및 그의 염, 그리고 농원예용 살균제
GB0919432D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Use
CA2779355C (en) 2009-11-05 2018-01-16 Glaxosmithkline Llc Benzodiazepine bromodomain inhibitor
GB0919426D0 (en) 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
AU2010317096B2 (en) 2009-11-05 2015-03-26 Glaxosmithkline Llc Benzodiazepine bromodomain inhibitor
ES2606958T3 (es) 2010-05-14 2017-03-28 Dana-Farber Cancer Institute, Inc. Compuestos de tienotriazolodiazepina para tratar una neoplasia
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
US11524938B2 (en) Aromatic sulfonamide derivatives
US20230346927A1 (en) COMBINATION of ATR KINASE INHIBITORS and PD-1/PD-L1 INHIBITORS
AU2014291711B2 (en) Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
US9890147B2 (en) 2,3-benzodiazepines
ES2727376T3 (es) Derivados de aminotriazina útiles como compuestos inhibidores de quinasa de unión TANK
JP2019504821A5 (enExample)
JP2017530999A5 (enExample)
AU2018309356B2 (en) Dihydrooxadiazinones
RU2017116598A (ru) Соединения и композиции для модуляции киназной активности мутантов egfr
JP7736669B2 (ja) [1,2,4]トリアゾロ[1,5-c]キナゾリン-5-アミン
EP3510024A1 (en) Pyridyl substituted indole compounds
JP7406592B2 (ja) 置換窒素含有化合物
SA517380830B1 (ar) 2-(مورفولين-4- يل)-7،1- نفثيريدينات
RU2019123319A (ru) Пиразолопиримидины и способы их применения
EA032416B1 (ru) Соединения триазолопиримидина и их применения
CA2521201A1 (en) Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors
US11660301B2 (en) Combination of ATR kinase inhibitors with PARP inhibitors
HRP20160421T1 (hr) Derivat azola
CA3022793C (en) Aromatic sulfonamide derivatives
RU2023132437A (ru) Производное бензамида, способ его получения и фармацевтическая композиция для профилактики или лечения рака, содержащая его в качестве активного ингредиента
EA040608B1 (ru) Ароматические сульфонамидные производные
BR112018072549B1 (pt) Derivados de sulfonamida aromática, seus intermediários, seus usos, e composição farmacêutica